Overview
Alopecia-intellectual disability-hypergonadotropic hypogonadism syndrome, also known as Perniola-Krajewska-Carnevale syndrome, is an extremely rare genetic condition characterized by the combination of hair loss (alopecia), intellectual disability, and hypergonadotropic hypogonadism (a condition in which the gonads fail to function properly despite elevated levels of stimulating hormones from the pituitary gland). The syndrome affects multiple body systems, including the integumentary system (skin and hair), the central nervous system (leading to cognitive impairment), and the endocrine/reproductive system (resulting in gonadal dysfunction and impaired sexual development or fertility). Clinical features typically include progressive or total alopecia, varying degrees of intellectual disability, and signs of gonadal failure such as delayed or absent puberty and elevated follicle-stimulating hormone (FSH) and luteinizing hormone (LH) levels. Additional features may vary among affected individuals. The condition has been described in only a very small number of families in the medical literature, making it one of the rarest recognized genetic syndromes. There is currently no cure or disease-specific treatment for this syndrome. Management is supportive and symptomatic, potentially including hormone replacement therapy to address hypogonadism, educational support and developmental interventions for intellectual disability, and dermatological consultation for alopecia. Genetic counseling is recommended for affected families.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
No FDA-approved treatments are currently listed for Alopecia-intellectual disability-hypergonadotropic hypogonadism syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Alopecia-intellectual disability-hypergonadotropic hypogonadism syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Alopecia-intellectual disability-hypergonadotropic hypogonadism syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Alopecia-intellectual disability-hypergonadotropic hypogonadism syndrome.
Community
No community posts yet. Be the first to share your experience with Alopecia-intellectual disability-hypergonadotropic hypogonadism syndrome.
Start the conversation →Latest news about Alopecia-intellectual disability-hypergonadotropic hypogonadism syndrome
No recent news articles for Alopecia-intellectual disability-hypergonadotropic hypogonadism syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Alopecia-intellectual disability-hypergonadotropic hypogonadism syndrome
What is Alopecia-intellectual disability-hypergonadotropic hypogonadism syndrome?
Alopecia-intellectual disability-hypergonadotropic hypogonadism syndrome, also known as Perniola-Krajewska-Carnevale syndrome, is an extremely rare genetic condition characterized by the combination of hair loss (alopecia), intellectual disability, and hypergonadotropic hypogonadism (a condition in which the gonads fail to function properly despite elevated levels of stimulating hormones from the pituitary gland). The syndrome affects multiple body systems, including the integumentary system (skin and hair), the central nervous system (leading to cognitive impairment), and the endocrine/reprod
How is Alopecia-intellectual disability-hypergonadotropic hypogonadism syndrome inherited?
Alopecia-intellectual disability-hypergonadotropic hypogonadism syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Alopecia-intellectual disability-hypergonadotropic hypogonadism syndrome typically begin?
Typical onset of Alopecia-intellectual disability-hypergonadotropic hypogonadism syndrome is childhood. Age of onset can vary across affected individuals.